JoVE Logo
Faculty Resource Center

Sign In

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

DOI :

10.3791/58133-v

June 28th, 2019

June 28th, 2019

22,384 Views

1Department of Molecular Medicine and the Center on Aging, The Scripps Research Institute, 2Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, 3Institute on the Biology of Aging and Metabolism, University of Minnesota

Cellular senescence is the key factor in the development of chronic age-related pathologies. Identification of therapeutics that target senescent cells show promise for extending healthy aging. Here, we present a novel assay to screen for the identification of senotherapeutics based on measurement of senescence associated β-Galactosidase activity in single cells.

-- Views

Related Videos

article

Identification and Analysis of Mouse Erythroid Progenitors using the CD71/TER119 Flow-cytometric Assay

article

Fluorescence-microscopy Screening and Next-generation Sequencing: Useful Tools for the Identification of Genes Involved in Organelle Integrity

article

A Fluorescent Screening Assay for Identifying Modulators of GIRK Channels

article

Identification of Post-translational Modifications of Plant Protein Complexes

article

RNA Catalyst as a Reporter for Screening Drugs against RNA Editing in Trypanosomes

article

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

article

Identification of Kinase-substrate Pairs Using High Throughput Screening

article

Chromatin Immunoprecipitation Assay for the Identification of Arabidopsis Protein-DNA Interactions In Vivo

article

Identification of Novel Regulators of Plant Transpiration by Large-Scale Thermal Imaging Screening in Helianthus Annuus

article

In situ Hybridization for Sipunculus nudus Coelomic Fluid

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved